insitro
Building a High-Performing Executive Team to Empower the CEO and Integrate Science & Technology
Backed by investors ARCH Venture Partners and GV, insitro uses machine learning and high-throughput biology to transform medicine discovery and development. By partnering with Occam, insitro successfully integrated its AI and drug discovery teams, establishing itself as a category leader and accelerating business growth.
THE CHALLENGE
Insitro faced a pivotal leadership gap: assembling a well-balanced executive team capable of bridging computer science and drug discovery, the two core pillars of this radical enterprise. The goal was to free the founder from day-to-day technical execution while ensuring cross-functional alignment across science, technology, and operations.
THE SOLUTION
Building Strategic Leadership Capacity:
Our first priority was recruiting a senior leader in data science and machine learning with a strong focus on drug discovery. This hire enabled Daphne Koller to step fully into her CEO role, orchestrating enterprise strategy, driving external partnerships, and shaping insitro’s public identity, while leaving deep technical execution in expert hands.
Establishing Multidisciplinary Executive Bench:
We identified and placed executives who combined AI/ML expertise with drug discovery fluency, ensuring technical depth and cross-domain agility. Additionally, strategic appointments such as a Chief People Officer ensured robust leadership across organizational complexity, empowering teams to scale efficiently while maintaining cultural cohesion.
Contact us today to build your life science executive team and define your next strategic move.
THE IMPACT
Accelerated Integration of AI and Drug Discovery:
insitro strengthened the connection between machine learning and therapeutic development, translating computational insights into actionable drug discovery programs more rapidly and cohesively.
Positioning for Category Leadership:
These strategic hires reinforced insitro’s identity as a TechBio innovator, boosting credibility with investors, partners, and top-tier talent.
FROM THE CLIENT
“
Building a company with a transformative mission requires having the very best people on your team from the very start. That requires a trusted partner who understands both the high-level strategic vision and the details of what it takes to succeed. Occam’s partnership in identifying and recruiting leaders for key positions at insitro has helped us close critical and hard-to-fill roles across scientific and corporate functions. We are consistently impressed by Occam's ability to deliver excellent results, which has enabled our continued growth and evolution.
”
Daphne Koller
Founder & CEO, insitro
IN SUMMARY
We are proud to have helped insitro evolve from a founder-led startup into a disruptive life science leader. By strategically recruiting cross-functional, high-impact executives, we enable CEOs to focus on enterprise leadership, drive innovation, and position their companies for long-term growth.
CONTACT US TO HELP BUILD YOUR LIFE SCIENCE EXECUTIVE TEAM.
FAQ
LEARN MORE ABOUT OUR DISTINCTIVE APPROACH
What is Occam Global's core expertise in executive search?
We are specialists in recruiting C-suite executives and board members for the life science, deep tech, robotics and defense tech industries. We also serve a select group of high-growth technology clients and venture capital firms, uniquely positioning us for techbio executive search.
What is the global reach of Occam Global's executive search services?
With associates in key innovation hubs New York City, San Francisco, and Los Angeles, we successfully place C-suite executives and board members for clients across the US and Europe.
Beyond executive search, what other leadership services does Occam Global offer?
In addition to global executive recruiting and board placement, we provide leadership advisory services to help shape and strengthen your organization's C-suite growth strategies through strategic partnerships and funding resources.
